🇺🇸 FDA
Patent

US 7378403

Akt inhibitors, pharmaceutical compositions, and uses thereof

granted A61PA61P11/00A61P11/08

Quick answer

US patent 7378403 (Akt inhibitors, pharmaceutical compositions, and uses thereof) held by The United States of America, as represented by the Department of Health and Human Services expires Mon May 22 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue May 27 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 22 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
54
CPC classes
A61P, A61P11/00, A61P11/08, A61P15/00, A61P17/00